4-(2-keto-1-benzimidazolinyl)piperidine compounds as ORL1-receptor agonists
US6423725B1 · kind B1 · utility
10Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 6, 2000 |
| Grant date | Jul 23, 2002 |
| Priority date | — |
| Expiry date | Mar 6, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D409/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of the formula: or the pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4 and R5 are defined above are useful as ORL1-receptor agonists, and useful as analgesics or the like in mammalian subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.